During cardiac hypertrophy, the overexpression of miR-99 facilitates the transition from physiological hypertrophy to pathological hypertrophy, and silencing of miR-99 has the opposite effect, through the regulation of the Akt-1 pathway (Ramasamy et al., 2018). This evidence concerns the gene AKT1 and cardiac hypertrophy.